| Reference |
|---|
Oostveen R, Kaiser Y, Hartgers M, Meessen E, Grefhorst A, Hovingh G, et al. Ursodeoxycholic Acid for Trans Intestinal Cholesterol Excretion Stimulation: A Randomized Placebo Controlled Crossover Study. J Am Heart Assoc. 2024;13:e035259 pubmed publisher |
Wahlstr xf6 m A, Aydin x, Olsson L, Sj xf6 land W, Henricsson M, Lundqvist A, et al. Alterations in bile acid kinetics after bariatric surgery in patients with obesity with or without type 2 diabetes. EBioMedicine. 2024;106:105265 pubmed publisher |
Xue T, Wang X, Pan X, Liu M, Xu F. PTX promotes breast cancer migration and invasion by recruiting ATF4 to upregulate FGF19. Cell Signal. 2024;122:111309 pubmed publisher |
Christidis G, K xfc ppers F, Karatayli S, Karatayli E, Weber S, Lammert F, et al. Skin advanced glycation end-products as indicators of the metabolic profile in diabetes mellitus: correlations with glycemic control, liver phenotypes and metabolic biomarkers. BMC Endocr Disord. 2024;24:31 pubmed publisher |
Goralska J, Razny U, Gruca A, Zdzienicka A, Micek A, Dembinska Kiec A, et al. Plasma Cytokeratin-18 Fragment Level Reflects the Metabolic Phenotype in Obesity. Biomolecules. 2023;13: pubmed publisher |
Ali R, Quinn G, Umarova R, Haddad J, Zhang G, Townsend E, et al. Longitudinal multi-omics analyses of the gut-liver axis reveals metabolic dysregulation in hepatitis C infection and cirrhosis. Nat Microbiol. 2023;8:12-27 pubmed publisher |
Yuan X, Wang R, Han B, Sun C, Chen R, Wei H, et al. Functional and metabolic alterations of gut microbiota in children with new-onset type 1 diabetes. Nat Commun. 2022;13:6356 pubmed publisher |
Sydor S, Dandyk C, Schwerdt J, Manka P, Benndorf D, Lehmann T, et al. Discovering Biomarkers for Non-Alcoholic Steatohepatitis Patients with and without Hepatocellular Carcinoma Using Fecal Metaproteomics. Int J Mol Sci. 2022;23: pubmed publisher |
Guo J, Chen H, Lee W, Chen S, Lee S, Chen C. Fibroblast Growth Factor 19 and Fibroblast Growth Factor 21 Regulation in Obese Diabetics, and Non-Alcoholic Fatty Liver Disease after Gastric Bypass. Nutrients. 2022;14: pubmed publisher |
Memon N, Lee C, Herdt A, WEINBERGER B, Hegyi T, Carayannopoulos M, et al. Suppression of Bile Acid Synthesis in a Preterm Infant Receiving Prolonged Parenteral Nutrition. J Clin Exp Hepatol. 2022;12:200-203 pubmed publisher |
Wang J, Zhao H, Zheng L, Zhou Y, Wu L, Xu Y, et al. FGF19/SOCE/NFATc2 signaling circuit facilitates the self-renewal of liver cancer stem cells. Theranostics. 2021;11:5045-5060 pubmed publisher |
Mao F, Wang M, Hou X, Zhou Z, Yan Y, Fang L, et al. NTCP Deficiency Causes Gallbladder Abnormalities in Mice and Human Beings. Cell Mol Gastroenterol Hepatol. 2021;11:831-839 pubmed publisher |
Wilson A, Wang Q, Almousa A, Jansen L, Choi Y, Schwarz U, et al. Genetic variation in the farnesoid X-receptor predicts Crohn's disease severity in female patients. Sci Rep. 2020;10:11725 pubmed publisher |
Liu W, Tang M, Xu T, Su J, Wang X, Xu F, et al. Association of serum fibroblast growth factor 19 levels with arteriosclerosis parameters assessed by arterial stiffness and atherogenic index of plasma in patients with type 2 diabetes. Diabetol Metab Syndr. 2020;12:44 pubmed publisher |
Calderon G, McRae A, Rievaj J, Davis J, Zandvakili I, Linker Nord S, et al. Ileo-colonic delivery of conjugated bile acids improves glucose homeostasis via colonic GLP-1-producing enteroendocrine cells in human obesity and diabetes. EBioMedicine. 2020;55:102759 pubmed publisher |
Goralska J, Razny U, Polus A, Dziewońska A, Gruca A, Zdzienicka A, et al. Enhanced GIP Secretion in Obesity Is Associated with Biochemical Alteration and miRNA Contribution to the Development of Liver Steatosis. Nutrients. 2020;12: pubmed publisher |
Wilson A, Almousa A, Teft W, Kim R. Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn's disease. Sci Rep. 2020;10:1866 pubmed publisher |
O Mara A, Johnson J, Linderman J, Brychta R, McGehee S, Fletcher L, et al. Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity. J Clin Invest. 2020;130:2209-2219 pubmed publisher |
Tang M, Su J, Xu T, Wang X, Zhang D, Wang X. Serum fibroblast growth factor 19 and endogenous islet beta cell function in type 2 diabetic patients. Diabetol Metab Syndr. 2019;11:79 pubmed publisher |
Appleby R, Moghul I, Khan S, Yee M, Manousou P, Neal T, et al. Non-alcoholic fatty liver disease is associated with dysregulated bile acid synthesis and diarrhea: A prospective observational study. PLoS ONE. 2019;14:e0211348 pubmed publisher |
Gao L, Lang L, Zhao X, Shay C, Shull A, Teng Y. FGF19 amplification reveals an oncogenic dependency upon autocrine FGF19/FGFR4 signaling in head and neck squamous cell carcinoma. Oncogene. 2019;38:2394-2404 pubmed publisher |
Morville T, Sahl R, Trammell S, Svenningsen J, Gillum M, Helge J, et al. Divergent effects of resistance and endurance exercise on plasma bile acids, FGF19, and FGF21 in humans. JCI Insight. 2018;3: pubmed publisher |
Cui G, Martin R, Jin H, Liu X, Pandit H, Zhao H, et al. Up-regulation of FGF15/19 signaling promotes hepatocellular carcinoma in the background of fatty liver. J Exp Clin Cancer Res. 2018;37:136 pubmed publisher |
Friedrich D, Marschall H, Lammert F. Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial. BMC Gastroenterol. 2018;18:76 pubmed publisher |
Al Dury S, Wahlström A, Wahlin S, Langedijk J, Elferink R, Ståhlman M, et al. Pilot study with IBAT inhibitor A4250 for the treatment of cholestatic pruritus in primary biliary cholangitis. Sci Rep. 2018;8:6658 pubmed publisher |
Lee J, Ong J, Vergnes L, de Aguiar Vallim T, Nolan J, Cantor R, et al. Diet1, bile acid diarrhea, and FGF15/19: mouse model and human genetic variants. J Lipid Res. 2018;59:429-438 pubmed publisher |
Valentin N, Camilleri M, Carlson P, Harrington S, Eckert D, O Neill J, et al. Potential mechanisms of effects of serum-derived bovine immunoglobulin/protein isolate therapy in patients with diarrhea-predominant irritable bowel syndrome. Physiol Rep. 2017;5: pubmed publisher |
Straniero S, Rosqvist F, Edholm D, Ahlstrom H, Kullberg J, Sundbom M, et al. Acute caloric restriction counteracts hepatic bile acid and cholesterol deficiency in morbid obesity. J Intern Med. 2017;281:507-517 pubmed publisher |
Martínez de la Escalera L, Kyrou I, Vrbikova J, Hainer V, Sramkova P, Fried M, et al. Impact of gut hormone FGF-19 on type-2 diabetes and mitochondrial recovery in a prospective study of obese diabetic women undergoing bariatric surgery. BMC Med. 2017;15:34 pubmed publisher |
Biemann R, Penner M, Borucki K, Westphal S, Luley C, Rönicke R, et al. Serum bile acids and GLP-1 decrease following telemetric induced weight loss: results of a randomized controlled trial. Sci Rep. 2016;6:30173 pubmed publisher |
Mouzaki M, Wang A, Bandsma R, Comelli E, Arendt B, Zhang L, et al. Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease. PLoS ONE. 2016;11:e0151829 pubmed publisher |
Gomez Ospina N, Potter C, Xiao R, Manickam K, Kim M, Kim K, et al. Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis. Nat Commun. 2016;7:10713 pubmed publisher |
Styer A, Roesch S, Argyropoulos G. Modulation of fibroblast growth factor 19 expression by bile acids, meal replacement and energy drinks, milk, and coffee. PLoS ONE. 2014;9:e85558 pubmed publisher |
Wang D, Zhu W, Li J, An C, Wang Z. Serum concentrations of fibroblast growth factors 19 and 21 in women with gestational diabetes mellitus: association with insulin resistance, adiponectin, and polycystic ovary syndrome history. PLoS ONE. 2013;8:e81190 pubmed publisher |
Feng S, Dakhova O, Creighton C, Ittmann M. Endocrine fibroblast growth factor FGF19 promotes prostate cancer progression. Cancer Res. 2013;73:2551-62 pubmed publisher |
Pournaras D, Glicksman C, Vincent R, Kuganolipava S, Alaghband Zadeh J, Mahon D, et al. The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology. 2012;153:3613-9 pubmed publisher |
Song K, Li T, Owsley E, Strom S, Chiang J. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression. Hepatology. 2009;49:297-305 pubmed publisher |
